PACKAGE LEAFLET: INFORMATION FOR THE USER
Donepezil Normon 5 mg orodispersible tablets EFG
Donepezil hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
5 Storage of Donepezil Normon
Donepezil Normon is a specific and reversible inhibitor of acetylcholinesterase, the predominant cholinesterase in the brain.
It is used for the symptomatic treatment of mild to moderately severe Alzheimer's disease.
Do not takeDonepezil Normon
Special warnings and precautions
Other medicines and Donepezil Normon
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription, especially if you are taking any of the following medicines:
Taking Donepezil Normon with alcohol may reduce the absorption of this medicine.
Taking Donepezil Normon with food and drinks
Place the tablet on the tongue and let it dissolve. Swallow with or without water.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Donepezil Normon if you are pregnant.
Do not take Donepezil Normon if you are breastfeeding.
Driving and using machines
Your illness may affect your ability to drive or use machines, and you should not carry out these activities unless your doctor tells you it is safe to do so. Donepezil Normon may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose. If you experience these effects, do not drive or use machines.
Important information about some of the ingredients of Donepezil Normon
Lactose:
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Aspartame:
This medicine contains 5 mg of aspartame in each orodispersible tablet.
Aspartame is a source of phenylalanine that may be harmful in people with phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body cannot eliminate it properly.
Sodium:
This medicine contains less than 23 mg of sodium (1 mmol) per orodispersible tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
Donepezil Normon is administered orally. The tablet should be placed on the tongue and allowed to dissolve before swallowing with or without water.
Treatment with Donepezil Normon starts with one 5 mg tablet, taken once daily, in the evening, immediately before bedtime. After one month of treatment, your doctor may instruct you to increase the dose to 10 mg, once daily, in the evening. The maximum recommended dose is 10 mg/day.
If you experience abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take Donepezil Normon in the morning.
If you have mild or moderate hepatic insufficiency (a disease that affects the liver) or renal insufficiency (a disease that affects the kidneys), you may follow a similar dosage regimen as indicated above.
If you take more Donepezil Normon than you should
If you have taken more Donepezil Normon than you should, contact your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.
If you forget to take Donepezil Normon
Do not take a double dose to make up for forgotten doses.
If you stop taking Donepezil Normon
Do not stop treatment without consulting your doctor first, even if you feel well.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects:
See a doctor immediately if you experience these serious side effects. You may need urgent medical treatment.
The estimated frequency of occurrence is as follows:
The most common side effects that may affect at least 1 in 10 people are:
Common side effects that may affect up to 1 in 100 people but more than 1 in 10 are:
Uncommon side effects that may affect up to 1 in 1,000 people but more than 1 in 100 are:
Rare side effects that may affect less than 1 in 1,000 people are:
Side effects with unknown frequency that cannot be estimated from the available data are:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Donepezil Normon
Appearance and packaging
Donepezil Normon is presented in orodispersible tablets, which dissolve in the mouth. The orodispersible tablets of Donepezil Normon 5 mg are flat, round, with beveled edges, and white or almost white in color, engraved with '5' on one face and flat on the other.
Donepezil Normon 5 mg is available in PVC/PCTFE (Aclar)/Aluminum blister packs of 7, 14, 28, 30, 50, 56, 60, 98, and 120 orodispersible tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of last revision of this leaflet:October 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/75006/P_75006.html